126 related articles for article (PubMed ID: 27131312)
1. RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells.
Lu M; Miao Y; Qi L; Bai M; Zhang J; Feng Y
Oncol Res; 2016; 23(6):267-74. PubMed ID: 27131312
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of FKBP14 on human cervical cancer cells.
Sun LY; Tao JZ; Yan B; Lin JS
Mol Med Rep; 2017 Oct; 16(4):4265-4272. PubMed ID: 28731139
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells.
Lin Y; Peng S; Yu H; Teng H; Cui M
Med Oncol; 2012 Mar; 29(1):311-7. PubMed ID: 21287298
[TBL] [Abstract][Full Text] [Related]
4. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
5. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
6. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
7. FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Huang Z; Li J; Du S; Tang Y; Huang L; Xiao L; Tong P
Oncotarget; 2016 Jun; 7(26):39872-39884. PubMed ID: 27223089
[TBL] [Abstract][Full Text] [Related]
8. MiR-361 inhibits osteosarcoma cell lines invasion and proliferation by targeting FKBP14.
Wang K; Qi XJ; Liu HZ; Su H
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):79-86. PubMed ID: 29364473
[TBL] [Abstract][Full Text] [Related]
9. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells.
Wang R; Fang H; Fang Q
Oncol Lett; 2017 Apr; 13(4):2811-2816. PubMed ID: 28454471
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
12. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A
Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
14. Role of Hydroxysteroid Dehydrogenase-Like 2 (HSDL2) in Human Ovarian Cancer.
Sun Q; Zhang Y; Su J; Li T; Jiang Y
Med Sci Monit; 2018 Jun; 24():3997-4008. PubMed ID: 29894468
[TBL] [Abstract][Full Text] [Related]
15. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
16. FKBP14 is an essential gene that regulates Presenilin protein levels and Notch signaling in Drosophila.
van de Hoef DL; Bonner JM; Boulianne GL
Development; 2013 Feb; 140(4):810-9. PubMed ID: 23318643
[TBL] [Abstract][Full Text] [Related]
17. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
19. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
[TBL] [Abstract][Full Text] [Related]
20. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]